Stocktoria
Greenland Mines Ltd GRML
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2022-04-29
Chart by TradingView
3/9
Piotroski F — financial health
69.33
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Financials | ||||
| Operating income | -$7.1M | -$5.5M | -$631,322 | -$657,018 |
| Net income | -$10.6M | -$6.2M | -$707,458 | $1.2M |
| Operating cash flow | -$5.9M | -$2.9M | -$446,916 | -$493,043 |
| Total assets | $9.6M | $2.5M | $2.2M | $118.2M |
| Total liabilities | $129,764 | $1.3M | $1.6M | $4.9M |
| Shareholders' equity | $9.5M | $1.2M | -$442,701 | -$4.0M |
| Ratios | ||||
| Return on assets | -110.0% | -250.3% | -32.3% | 1.0% |
| Return on equity | -111.5% | -518.9% | 159.8% | -30.5% |
| Current ratio | 95.01 | 0.13 | 0.00 | 0.87 |
Why these scores methodology →
Piotroski F-score: 3/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 69.33 (safe)
- Working capital / assets 0.752
- Retained earnings / assets -2.201
- EBIT / assets -0.745
- Equity / liabilities 72.928
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001907223 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.